SCHEMBL2723907

SCHEMBL2723907

CCCCOC(=O)C1CCC(c2cc(N)n3nccc3n2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.45
CHEK1 O14757 1/20 0.45
CCNA2 P20248 1/20 0.45
CCNA1 P78396 1/20 0.45
PDE10A Q9Y233 1/20 0.38
SYK P43405 7/20 0.38
CDK7 P50613 2/20 0.37
CDK9 P50750 2/20 0.37
CCNT1 O60563 1/20 0.37
CCNH P51946 1/20 0.37
CDK13 Q14004 1/20 0.34
CDK12 Q9NYV4 1/20 0.34
JAK1 P23458 1/20 0.34
DGAT1 O75907 1/20 0.34
KDM4E B2RXH2 2/20 0.34
SRC P12931 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6890507 0.81 CDK2 (0.48) CDK2CHEK1CCNA2CCNA1PDE10A
SCHEMBL10277723 0.81 CDK2 (0.48) CDK2CHEK1CCNA2CCNA1PDE10A
SCHEMBL10236616 0.78 CDK2 (0.49) CDK2CHEK1CCNA2CCNA1PDE10A
SCHEMBL1074061 0.74 LGMN (0.40) CDK2CHEK1CCNA2CCNA1JAK1
SCHEMBL2679820 0.71 PDE10A (0.41) CDK2CHEK1CCNA2CCNA1PDE10A
SCHEMBL42979 0.71 CDK2 (0.43) CDK2CHEK1CCNA2CCNA1PDE10A
SCHEMBL593655 0.71 CDK2 (0.54) CDK2CHEK1CCNA2CCNA1PDE10A
SCHEMBL584858 0.70 CHEK1 (0.59) CDK2CHEK1CCNA2CCNA1PDE10A
SCHEMBL2680236 0.69 GPR119 (0.48) CDK2CHEK1CCNA2CCNA1KDM4E
SCHEMBL16104450 0.69 SMN1; SMN2 (0.38) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027240-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed